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Chemical manipulations of small molecule metabolites take place in all living systems and 
are essential for sustaining life through cellular metabolism.[1] The vast majority of these 
transformations are carried out by macromolecular, enzymatic catalysts. In contrast to the 
natural world, most chemical reactions employed in laboratory syntheses utilize non-
biological reagents and catalysts.[2] Although non-biological catalysts and reagents have 
been shown to function in the presence of cells,[3] the question of whether their reactivity 
can interface with cellular metabolism and influence biological function remains 
underexplored. We are interested in further developing this aspect of reaction methodology, 
which we term biocompatible chemistry: non-enzymatic chemical transformations that can 
be used to manipulate the structures of small molecules in the presence of living organisms. 
Successful integration of biocompatible chemistry with cellular metabolism would have 
implications for biotechnology as it could expand the capabilities of biotransformation in 
ways that are not possible using enzymes. Establishing a link between non-enzymatic 
catalysis and metabolism could also have potential implications for prebiotic chemistry, as it 
would suggest that primitive cells could have relied upon non-enzymatic transformations 
occurring in the surrounding environment to generate essential metabolites.[4] Here we 
describe biocompatible chemical reactions that interact with microbial metabolism and 
rescue auxotrophy through the production of essential metabolites. This experimental 
approach enables us to directly connect the growth of a living organism to the success of a 
non-biological chemical transformation.
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Auxotrophs are organisms that lack the ability to synthesize key nutrients required for 
growth and survival.[5] The necessary compounds must instead be obtained from external 
sources, typically the diet or metabolic activities of other organisms living in close 
proximity. The numerous examples of auxtotrophs in Nature include humans, who are 
unable to synthesize many essential vitamins and metabolites. It is possible to rescue 
auxotrophy in bacteria by transformation with genes encoding enzymes that can replace or 
complement the missing metabolic activity. Restoration of growth in this way constitutes an 
extremely powerful strategy for selection of evolved biomolecules in the context of directed 
evolution.[6] Recently, Hecht and co-workers demonstrated that it is possible to rescue the 
growth of E. coli auxotrophs using de novo protein scaffolds not found in natural systems.[7] 
Significantly, this result implies that catalysts other than native enzymes can replace key 
metabolic functions in living cells.
Our interest in merging non-enzymatic chemistry with metabolism led us to explore whether 
reactions carried out by non-biological catalysts could support the growth of auxotrophic 
microorganisms (Figure 1A). Rescue of auxotrophy in this manner requires linking a 
transformation of interest to production of an essential cellular metabolite. We decided to 
initially apply a ruthenium-catalyzed Alloc deprotection reaction developed by Streu and 
Meggers that had been previously used in human cell culture.[8] We envisioned connecting 
this reaction to release of p-aminobenzoic acid (PABA), a biosynthetic precursor to folic 
acid (Figure 1B). Organisms that cannot biosynthesize PABA are unable to grow because of 
defects in nucleotide metabolism. By using the Alloc deprotection to generate PABA, the 
success of this non-enzymatic reaction would enable growth of PABA auxotrophs.
We accessed putative rescue substrate Alloc-PABA (1) in a single step as reported 
previously.[9] We then evaluated whether this transformation could take place in growth 
media. Using 20 µM [Cp*Ru(cod)Cl] (2) as a catalyst in PABA-free M9 glycerol minimal 
medium at 37 °C, we were able to detect formation of PABA from 100 µM 1 (Table 1, Entry 
1). As was observed previously, inclusion of a thiol additive boosted conversion (Entries 2, 
3). Production of PABA was dependent on the presence of catalyst 2 (Entry 4) and was also 
observed at lower substrate concentrations (Entry 5). Overall, these experiments verified that 
deprotection could proceed in media, albeit with low efficiency.
Testing the ability of this reaction to rescue PABA auxotrophy required a microorganism 
that was unable to synthesize this metabolite. We obtained three different E. coli mutants 
from the Keio collection that are PABA auxotrophs (Figure 1C).[10] Two of these strains 
(ΔpabA and ΔpabB) have mutations in the genes encoding the two subunits of 
aminodeoxychorismate synthase, which catalyzes the penultimate step in PABA 
biosynthesis.[11] The third mutant (ΔaroC) is missing the gene encoding key shikimate 
pathway enzyme chorismate synthase, and is unable to synthesize not only PABA but also 
the aromatic amino acids L-phenylalanine, L-tyrosine, and L-tryptophan, as well as the 
aromatic metabolites para-hydroxybenzoic acid (PHBA) and 2,3-hydroxybenzoic acid.[12] 
We confirmed that all three strains were unable to grow in PABA-free M9 glycerol minimal 
media and established each strain’s inability to utilize substrate 1 in place of PABA. All 
media used for the ΔaroC mutant were supplemented with the additional required nutrients. 
As strains from the Keio collection contain a kanamycin resistance cassette, we routinely 
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cultivated the auxotrophs in media containing this antibiotic to prevent contamination with 
wild type strains.
We evaluated whether Ru-catalyzed deprotection of 1 could restore the growth of these 
strains by serially diluting overnight cultures of ΔpabA, ΔpabB, and ΔaroC mutants into 
PABA-free M9 glycerol minimal media, inoculating each strain into PABA-free M9 
glycerol minimal media containing 10 µM 1, adding catalyst 2 to the cultures at a final 
concentration of 2 µM, and then incubating the cultures at 37 °C. At the same time, we also 
inoculated the auxotrophs into M9 glycerol minimal media containing 10 µM PABA 
(positive control), M9 glycerol minimal media lacking both PABA and 1, and PABA-free 
M9 glycerol minimal media containing 10 µM 1 (negative controls). Measurement of the 
optical density of the cultures (OD600) after 48 h revealed considerable growth of each of 
the mutant strains in the presence of substrate 1 and catalyst 2 (Figure 2A,B). The final 
optical densities were comparable to the cultures grown in the presence of PABA. As 
expected, no growth was observed in the absence of PABA. We evaluated the time course of 
growth under each of these conditions by recording growth curves over 72 h. Growth curves 
for mutants rescued by 1 and 2 and mutants grown in media containing 10 µM PABA were 
similar, with only the rescued ΔpabA mutant reaching a lower optical density (Figure 2C). 
We delineated the requirements for successful auxotroph rescue with a series of control 
reactions, varying the components of the defined minimal media and measuring final OD600 
after 48 h at 37 °C (Table S3). We found that the presence of substrate 1 and catalyst 2 are 
both essential. Thiol addition had a minimal impact on growth, perhaps indicating that the 
improved conversion observed with these additives does not affect the efficiency of rescue. 
This result could also suggest that thiols generated by E. coli are involved in the 
deprotection in vivo.
An alternate explanation for auxotroph rescue could be the accumulation of mutations 
during the course of the experiment that either alleviate PABA auxotrophy or enable the 
strains to generate PABA from substrate 1. We investigated these possibilities by re-
inoculating rescued cultures back into minimal media lacking PABA (Figure S3, Table S4). 
None of the rescued cultures grew under these conditions, confirming that they were still 
PABA auxotrophs. The rescued strains also remained unable to grow in PABA-free media 
containing 10 µM substrate 1, indicating that they had not acquired the ability to deprotect 
Alloc-PABA. All of the rescued cultures retained the ability to grow in media containing 
PABA and could be rescued a second time in PABA-free medium containing substrate 1 and 
catalyst 2. Finally, the fact that three auxotrophic strains, each containing a distinct 
mutation, were rescued using this deprotection reaction adds to the weight of evidence 
against genetic changes leading to bacterial growth in these experiments.
A final piece of evidence supporting the link between Alloc deprotection and growth was 
the detection of PABA in rescued cultures. We determined the concentration of PABA 
necessary to achieve rescue by inoculating ΔpabA and ΔaroC mutants into M9 glycerol 
minimal media containing varying amounts of PABA (10 µM – 10 pM). We found that at 
least 10 nM of PABA was required to rescue both mutant strains (Table S5). We then used 
liquid chromatography-mass spectroscopy (LC-MS) to quantify the PABA produced during 
a rescue experiment (Table S6). Analysis of culture medium after rescue of a ΔpabA mutant 
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revealed 60 nM PABA; therefore, the concentration of PABA generated from the Ru-
catalyzed deprotection of 1 is sufficient to allow growth of these auxotrophs. Although we 
detected PABA in the medium, we do not know to what extent deprotection occurs 
intracellularly vs. extracellularly; gaining a deeper understanding of where biocompatible 
reactions take place is a future area of interest.
This initial demonstration of auxotroph rescue relied upon a reaction that had previously 
been applied in living cells. We decided to explore the generality of this phenomenon by 
rescuing a different auxotrophy using iron(II)-catalyzed hydroxylation, a chemically 
challenging transformation that had not previously been utilized in the presence of living 
organisms. Hydroxylation of aromatic substrates in water using low valent transition metals 
and molecular oxygen has been extensively investigated, as these systems mimic the 
reactivity of monooxygenase enzymes.[13] In particular, oxygenation using iron(II) 
complexes, molecular oxygen, and reducing agents (ascorbic and citric acids) has been 
previously carried out in aqueous solvent at ambient temperatures, conditions that could 
potentially be compatible with living organisms.[14] These hydroxylations are thought to 
proceed via formation of reactive oxygen species, including hydroxyl radicals, making it 
unclear whether this type of transformation could be biocompatible.[15] However, this 
reaction has biological relevance, as it resembles chemistry that may have occurred during 
the oxygenation of the Earth’s atmosphere as molecular oxygen reacted with iron present in 
the environment.[16]
We envisioned rescuing the ΔaroC mutant, a p-hydroxybenzoic acid (PHBA) auxotroph, 
using iron-catalyzed para hydroxylation of benzoic acid (3) (Figure 3A). We first confirmed 
that the ΔaroC mutant could not grow in PHBA-free M9 glycerol minimal media and that 
media containing 100 µM benzoic acid did not rescue growth (Figure 3B). In analogy to the 
earlier rescue of PABA auxotrophy, growth media contained all nutrients required for 
growth except PHBA. We then inoculated the mutant into PHBA-free minimal media 
containing 3 (10, 100 or 200 µM), FeSO4 (10, 100 or 200 µM), and citric acid (0.2, 2 or 4 
mM).[14e] Both of the larger scale cultures were rescued. Control experiments revealed that 
all reaction components were required for growth (Table S7). Comparison of growth curves 
for cultures grown in the presence of PHBA and rescued cultures revealed a more 
pronounced delay of entry into exponential growth phase during rescue than was observed 
for the PABA auxotrophs (Figure 3C). We hypothesize that this difference may be due to 
cell death arising from reactive oxygen species generated during the hydroxylation reaction, 
which would reduce the inoculum. Similarly to the rescued PABA auxotrophs, rescued 
PHBA auxotrophs remained unable to grow in the presence of 3, indicating a key role for 
catalysis in restoration of growth (Table S8, Figure S4). Culturing the ΔaroC mutant in 
media containing varying amounts of PHBA revealed that 10–100 nM PHBA is sufficient 
for growth (Table S9). We confirmed that PHBA was produced in rescued cultures using 
LC-MS, detecting 70 nM of PHBA in media post-rescue (Table S10).
Unlike most enzymatic transformations that functionalize aromatic scaffolds, the iron-
catalyzed hydroxylation used to generate PHBA is not expected to be regioselective. To 
establish the selectivity of this reaction, we performed the hydroxylation in culture media 
using 1 mM 3. At this higher substrate concentration we could separate and quantify all 
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three monohydroxylation products using HPLC (Figure S5 and Table S11). As anticipated, 
the reaction provided a mixture of para, meta, and ortho hydroxylation products (Figure 
4D). This result indicates that a non-enzymatic transformation does not have to proceed with 
the same degree of selectivity as an enzymatic reaction to support growth, an observation 
that may have significance for prebiotic chemistry and the evolution of new enzymatic 
function. It also raises the question of whether there is residual promiscuity in native 
metabolic reactions and pathways that may provide insights into their origins.
In summary, we have demonstrated for the first time that biocompatible, non-enzymatic 
transformations can rescue the growth of auxotrophic microorganisms by generating 
essential metabolites. More broadly, this approach enables us to link growth of a living 
organism to the success of a non-biological reaction. We anticipate that this phenomenon 
will constitute a powerful strategy for screening and discovering new biocompatible 
chemistry. Important future challenges include establishing methods to discover more 
efficient transformations, as well as identifying reactions that can directly replace missing 
cellular enzymes for use within metabolic engineering and medicine. Overall, this work 
represents an important step toward interfacing biocompatible transformations with 
metabolism and constitutes a new way to apply synthetic chemistry in the context of 
biological systems.
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Rescuing auxotrophy with biocompatible chemistry. A) Overall strategy for auxotroph 
rescue. B) Plan for connecting biocompatible Alloc deprotection reaction to generation of 
the essential metabolite p-aminobenzoic acid (PABA). C) Biosynthesis of aromatic 
metabolites in E. coli and mutations leading to PABA and p-hydroxybenzoic acid (PHBA) 
auxotrophies.
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Biocompatible Alloc deprotection rescues growth of E. coli PABA auxotrophs. A) Final 
optical densities of E. coli mutants grown in 5 mL PABA-free M9 glycerol minimal media 
for 48 h at 37 °C. B) Image of ΔpabA mutant cultures after 48 h of growth. C) Growth 
curves of E. coli mutants grown in 150 µL of PABA-free M9 glycerol minimal media at 37 
°C. Growth curves shown are the average of three replicate cultures.
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Rescue of p-hydroxybenzoic acid (PHBA) auxotrophs using iron-catalyzed hydroxylation. 
A) Plan for generating PHBA through hydroxylation of benzoic acid. B) Final optical 
densities of E. coli ΔaroC mutant grown in 5 mL PHBA-free M9 glycerol minimal media 
for 48 h at 37 °C. C) Growth curves of ΔaroC mutant grown in 150 µL of PHBA-free M9 
glycerol minimal media at 37 °C. Growth curves shown are the average of three replicate 
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cultures. D) Selectivity of the FeSO4-catalyzed hydroxylation of benzoic acid. Product ratio 
determined by HPLC analysis.
Lee et al. Page 10

















Lee et al. Page 11
Table 1
Deprotection of 1 in the absence of cells.
Entry[a] 1 (µM) 2 (µM) Thiol Conversion[%][b]
1 100 20 none 8
2 100 20 PhSH 9
3 100 20 GSH 14
4 100 0 PhSH 0
5 10 2 GSH 2
[a]
Reactions were run on 5 mL scale for 48 h.
[b]Conversions were determined by HPLC analysis of reaction mixtures.
Abbreviations: PhSH = thiophenol, GSH = glutathione.
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